Remicade and Crohn's disease - a phase IV clinical study of FDA data
Crohn's disease is found among people who take Remicade, especially for people who are female, 10-19 old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Remicade and have Crohn's disease. It is created by eHealthMe based on reports of 201,081 people who have side effects when taking Remicade from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
201,081 people reported to have side effects when taking Remicade.
Among them, 8,065 people (4.01%) have Crohn's disease.
What is Remicade?
Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 202,415 Remicade users for its effectiveness, alternative drugs and more.
What is Crohn's disease?
Crohn's disease (condition that causes inflammation of the gastrointestinal tract) is found to be associated with 2,514 drugs and 1,968 conditions by eHealthMe.
Number of Remicade and Crohn's disease reports submitted per year:
Time on Remicade when people have Crohn's disease *:
Gender of people who have Crohn's disease when taking Remicade*:
Age of people who have Crohn's disease when taking Remicade *:
Common drugs people take besides Remicade *:
Common side effects people have besides Crohn's disease *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Remicade and have Crohn's disease?Check whether Crohn's disease is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Crohn's disease and when was it recovered:
Expand to all the drugs that have ingredients of infliximab:
- Crohn's disease and drugs with ingredients of infliximab (10,132 reports)
Alternative drugs to, pros and cons of Remicade:
- Remicade (202,415 reports)
Common Remicade side effects:
- Drug ineffective: 37,128 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 19,890 reports
- Pain: 15,979 reports
- Rashes (redness): 13,418 reports
- Joint pain: 13,157 reports
- Fatigue (feeling of tiredness): 12,449 reports
- Joint swelling: 10,802 reports
Browse all side effects of Remicade:a b c d e f g h i j k l m n o p q r s t u v w x y z
Crohn's disease treatments and more:
- Crohn's disease (311,603 reports)
COVID vaccines that are related to Crohn's disease:
- Crohn's disease in Moderna COVID Vaccine
- Crohn's disease in Pfizer BioNTech Covid Vaccine
- Crohn's disease in Johnson and Johnson Covid Vaccine
Common drugs associated with Crohn's disease:
- Humira: 20,999 reports
- Remicade: 8,065 reports
- Prednisone: 7,967 reports
- Accutane: 7,519 reports
- Methotrexate: 4,579 reports
- Stelara: 3,791 reports
- Cimzia: 3,233 reports
- Azathioprine: 2,537 reports
- Imuran: 1,872 reports
- Pentasa: 1,718 reports
All the drugs that are associated with Crohn's disease:
- Crohn's disease (2,514 drugs)
Common conditions associated with Crohn's disease:
- Acne: 4,791 reports
- Rheumatoid arthritis: 1,983 reports
- Pain: 1,966 reports
- High blood pressure: 1,721 reports
All the conditions that are associated with Crohn's disease:
- Crohn's disease (1,968 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Alendronate Sodium and Viral Pharyngitis - now
- Selenium and Beconase drug interaction - a second ago
- Infection and Melaena - 4 seconds ago
- Oxervate and Maxitrol drug interaction - 6 seconds ago
- Azathioprine and Embolex drug interaction - 10 seconds ago
- Flurazepam Hydrochloride vs. Zanaflex - 15 seconds ago
- Duragesic-100 and Paraesthesia Oral - 15 seconds ago
- Peg-Intron and Biliary Dilatation - 22 seconds ago
- Vancomycin and Tigecycline drug interaction - 30 seconds ago
- Wixela Inhub and Haematochezia - 36 seconds ago